✦ LIBER ✦

Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: The ROMA trial

✍ Scribed by Sardella, Gennaro; Conti, Giulia; Donahue, Michael; Mancone, Massimo; Canali, Emanuele; De Carlo, Carlotta; Di Roma, Angelo; Calcagno, Simone; Lucisano, Luigi; Fedele, Francesco

Book ID: 118753921
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 267 KB
Volume: 81
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.24403

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of high reloading ROsuvastati

Comparison of high reloading ROsuvastatin and Atorvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of MyocArdial periprocedural necrosis. The ROMA II trial

✍ Sardella, Gennaro; Lucisano, Luigi; Mancone, Massimo; Conti, Giulia; Calcagno, S 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 492 KB

Impact of Albuminuria on the Incidence o

Impact of Albuminuria on the Incidence of Periprocedural Myocardial Injury in Patients Undergoing Elective Coronary Stent Implantation

✍ Osugi, Naohiro; Suzuki, Susumu; Ishii, Hideki; Yasuda, Yoshinari; Shibata, Yohei 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 377 KB

Assessing the role of eptifibatide in pa

Assessing the role of eptifibatide in patients with diffuse coronary disease undergoing drug-eluting stenting: The INtegrilin plus STenting to Avoid myocardial Necrosis Trial

✍ Giuseppe Biondi-Zoccai; Marco Valgimigli; Massimo Margheri; Antonio Marzocchi; C 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 391 KB

CORRELATION OF C–REACTIVE PROTEIN LEVELS

CORRELATION OF C–REACTIVE PROTEIN LEVELS AND PLATELET REACTIVITY TO OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PCI: RESULTS OF THE ARMYDA–CRP (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY–C REACTIVE PROTEIN) PROSPECTIVE STUDY

✍ Ricottini, Elisabetta; Patti, Giuseppe; Mangiacapra, Fabio; Cavallari, Ilaria; C 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Short-Term, High-Dose Atorvastatin Pretr

Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty–Contrast-Induced Nephropathy] Trial

✍ Giuseppe Patti; Elisabetta Ricottini; Annunziata Nusca; Giuseppe Colonna; Vincen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 811 KB